Blog - Page 3562 of 5487

TuesdayJul 20, 2010 3:22 pm

White Mountain Titanium Corp. (WMTM.OB) to License New Breakthrough Titanium Processing Technology

White Mountain Titanium Corp., www.wmtcorp.com – owner of the Cerro Blanco rutile deposit in Region III of Northern Chile, a huge source of premium grade titanium dioxide (TiO2) concentrate for the paint and pigment markets, reported signing a Letter of Intent (L/I) to license the Chinuka Process, a new titanium metal technology. The Company, along with Sociedad Contractual Minera White Mountain Titanium (SCM-WMT; a WMTM wholly-owned Chilean subsidiary), La Serena Technologies Ltd., and Chinuka Limited plc, have entered into this L/I to license the Chinuka-developed process realized under the direction of University of Cambridge Professor and Director of Research, Materials…

TuesdayJul 20, 2010 3:18 pm

3DIcon Corp.’s (TDCP.OB) Breakthrough 3D Interface Technology will use Berkeley Lab Nanocrystals

3DIcon Corporation, www.3dicon.net – a pioneer developer of volumetric, full-color, 360-degree, 3D imaging technology for interfaces, visualization and other applications, today revealed the signing of a Materials Transfer Agreement (MTA) with University of California regents through Lawrence Berkeley National Laboratory, under a DOE contract, to obtain Berkeley Lab-developed nanocrystals for use in its work. Founder and CEO of TDCP, Martin Keating, commented on the Company’s completion and patenting of the rendering of 3D applications with the advent of the CSpace® system, and noted that software-layer advancements like Pixel Precision® represent tangible breakthroughs in 3D interface technology. Keating pointed to aspects…

TuesdayJul 20, 2010 3:16 pm

Sinobiopharma Inc. (SNBP.OB) Partners with Xianfeng Pharmaceuticals to Co-produce and Market Two Biopharm Technologies

Biopharmaceutical company Sinobiopharma Inc. focuses on anesthesia-assisted agents and cardiovascular drugs. The company today announced an agreement with Anhui Xianfeng Pharmaceuticals Co. Ltd (Xianfeng) to manufacture and co-market Clindamycin and L-alanyl-L-glutamine. Clindamycin is an antibiotic used to treat anaerobic bacterial infections, some protozoal diseases (such as malaria), and is also used as a topical acne treatment cream; parenteral nutrition product L-alanyl-L-glutamine is prescribed for patients after surgery. Sinobiopharma owns the drug certificates, drug registration approval documents and production technologies of the two products. Per the agreement, Xianfeng will pay Sinobiopharma to obtain access to the technologies. Xianfeng is equipped with…

TuesdayJul 20, 2010 3:15 pm

Lyfe Communications Inc. (LYFE.OB) Acquires Data Provisioning Rights from Ygnition Networks to Expand National Footprint

Lyfe Communications Inc. operates through its wholly owned subsidiary Connected Lyfe to provide next generation network platforms for entertainment and communications services. The company recently purchased the data provisioning rights to Ygnition Networks Inc.’s multi-family properties in Utah, reflecting efforts of its overall growth strategy. “Delivery of our network services to multi-family communities is central to our growth strategy,” Robert Bryson, president and CEO of Connected Lyfe stated in the press release. “By focusing on communities across the Wasatch Front we can deliver the level of service expected from a local company, and optimize our operations prior to expanding our…

TuesdayJul 20, 2010 11:46 am

New Tests Reveal BioSolar, Inc.’s (BSRC.OB) BioBacksheet Improves Solar Panel Efficiency and Power Output

BioSolar Inc. is the developer of a breakthrough technology to produce bio-based materials from renewable plant sources that will reduce the cost per watt of photovoltaic solar cells. Most of the solar industry is focused on photovoltaic efficiency to reduce cost, however, BioSolar's unique approach introduces a new dimension of cost reduction by replacing oil-based plastic solar cell components with durable bio-based materials. The efficiency of a photovoltaic solar module is determined by the percentage of the incoming solar radiation that is converted to electricity within the solar panel. The efficiency of popular silicon solar cells decreases dramatically as the…

TuesdayJul 20, 2010 11:42 am

NutraStar International, Inc. (NIUN.OB) Appoints Robert Tick as Chief Financial Officer

Nutrastar International Inc. is a leading China-based nutraceutical company which produces and distributes its primary product – dry engineered Chinese Golden Grass (Cordyceps Militaris) along with organic and specialty foods in China. Chinese Golden Grass, actually a type of mushroom, is one of the most highly regarded herbal nutrients in Chinese culture. The company believes it is the largest manufacturer of engineered Chinese Golden grass in China. According to the China Market Monitoring Center, Nutrastar International has a 19 percent market share for the product. For more information on the company and its products, visit the following website www.nutrastarintl.com. The…

TuesdayJul 20, 2010 9:48 am

Access Pharmaceuticals, Inc. (ACCP.OB) Signs Major Distribution Agreement with BioScrip

Access Pharmaceuticals, a biopharmaceutical company specializing in products for cancer and supportive care, announced today the signing of an agreement with BioScrip (NASDAQ: BIOS) for the distribution of MuGard, the lead product of Access. MuGard is an FDA approved oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy. The agreement provides for the distribution of MuGuard through BioScrip’s nationwide distribution platform, including 110 BioScrip specialty pharmacies. It also allows Access to leverage BioScrip’s extensive physician relationships, and provides for mail distribution and a diversified payor network. BioScrip is a national provider of…

TuesdayJul 20, 2010 9:11 am

Universal Detection Technology (UNDT.OB) Receives Groundbreaking Purchase

Located in Los Angeles, California, Universal Detection Technology has proven itself as a top-notch developer of monitoring technologies which include bioterrorism detection devices. Today, the young company announced that they received an order from Washington D.C.’s Office of Public Safety and Justice for their unique bio-terror and chemical weapon detection equipment. Universal Detection Technology’s products’ have gained recognition due to their successful early-warnings of the deadly threats of bioterrorism as well as other infectious health threats. The purchase order from the Office of Public Safety and Justice will add a great deal of credibility to the company. The purchase order…

TuesdayJul 20, 2010 9:08 am

Mueller Industries, Inc. (MLI) Reports Increase in Second Quarter Net Income

Mueller Industries, Inc. reported a strong year over year increase in earnings in the second quarter of 2010. The company reported net income of $15.6 million, or $0.41 per diluted share, compared to net income of $6.0 million, or $0.16 per diluted share, in the second quarter of 2009. Mueller Industries, Inc. also reported a jump in revenues for the quarter that just ended, which came in at $540.4 million, compared to $367.8 million in the same quarter in 2009. The company said that the large increase in revenues was due to the soaring price of copper, which was up…

TuesdayJul 20, 2010 9:07 am

MGIC Investment Corp. (MTG) Reports Profit in Second Quarter of 2010

MGIC Investment Corp. reported results for the second quarter ending 6/30/2010. The company earned net income of $24.6 million, or $0.13 per diluted share. MGIC Investment Corporation reported a net loss of $339.8 million, or $2.74 per diluted share, in the same quarter of 2009. MGIC Investment Corporation reported that sales in the second quarter of 2010 were down on a year over year basis. The company reported sales of $406.4 million in the quarter that just ended, compared to $454.5 million in the same quarter in 2009. Net premiums written by MGIC Investment Corporation also declined on a year…

Site Search

Company Search